Abstract
Introduction
In this study, we have investigated the role of leptin, soluble leptin receptor(sOb-R), resistin, and insulin secretory dynamics in the development of hypothalamic obesity.
Materials and methods
Children who had hypothalamo-pituitary tumor were divided into two groups. First group included obese-overweight (hypothalamic obese = HOB group, n = 23) and second group included non-obese children (hypothalamic non-obese = HNOB group, n = 16). Exogenously obese-overweight children (OB group, n = 22) were included as controls. Basal and second-hour serum glucose and insulin in oral glucose tolerance test (OGTT), basal serum leptin, sOb-R, resistin levels, and homeostasis model assessment (HOMA) indexes were compared between the groups.
Results
Age, sex, and pubertal status were similar in study groups. Median and interquartile ranges of body mass index (BMI) z scores were similar in HOB and OB groups (2.0 (1.5–2.1) and 2.1 (1.8–2.3), respectively). Serum leptin levels corrected for BMI were highest and total leptin/sOb-R ratios (free leptin index (FLI)) tended to be higher in HOB than HNOB and OB groups, indicating leptin resistance (leptin/BMI, 4.0 (1.6–5.2), 1.5 (0.8–3.1), and 2.5 (1.8–3.5); FLI, 2.0 (0.8–3.5), 0.6 (0.3–1.2), and 1.5 (1–2.3) in HOB, HNOB, and OB groups; respectively). Serum resistin levels were similar in groups (2.6 (1.9–3.1), 2.8 (1.7–3.4), and 3.0 (2.2–3.5) ng/ml in HOB, HNOB, and OB groups, respectively). Basal serum glucose, basal and second-hour insulin levels in OGTT, and HOMA index were higher in OB group than the HOB and HNOB groups, indicating insulin resistance in simple obesity; however, increment of insulin to same glycemic load in OGTT was highest in the HOB group indicating insulin dysregulation (p < 0.05).
Conclusion
Hypothalamic obesity seems to be related to both dysregulated afferent (leptin) and efferent (insulin) neural outputs through the autonomic nervous system resulting in energy storage as fat.
Similar content being viewed by others
Abbreviations
- sOb-R:
-
soluble leptin receptor
- HOB:
-
Hypothalamic obese
- HNOB:
-
Hypothalamic non-obese
- OB:
-
Obese
- OGTT:
-
Oral glucose tolerance test
- BMI:
-
Body mass index
- FLI:
-
Free leptin index
- HOMA-IR:
-
Homeostasis model assessment for insulin resistance index
References
Ainsworth BE, Haskell WL, Leon AS (1993) Compendium of physical activities: classification of energy costs of human physical activities. Med Sci Sports Exerc 25(1):71–80
American Diabetes Association (2000) Type 2 diabetes in children (consensus statement). Diabetes Care 23(3):381–389
Anderlová K, Kremen J, Dolezalová R (2006) The influence of very-low-calorie-diet on serum leptin, soluble leptin receptor, adiponectin and resistin levels in obese women. Physiol Res 55(3):277–283
Banerjee RR, Rangwala SM, Shapiro JS (2004) Regulation of fasted blood glucose by resistin. Science 303:1195–1198
Bray GA, York DA (1979) Hypothalamic and genetic obesity in experimental animals: an autonomic and endocrine hypothesis. Physiol Rev 59(3):719–809
Chanchay S, Tungtrongchitr R, Harnroongroj T (2006) Plasma resistin, insulin concentration in non-diabetic and diabetic, overweight/obese Thai. Int J Vitam Nutr Res 76(3):125–131
Cole TJ, Bellizzi MC, Flegal KM, Dietz WH (2000) Establishing a standard definition for child overweight and obesity worldwide: international survey. BMJ 320(7244):1240–1243
Housová J, Anderlová K, Křížová J (2004) Serum adiponectin and resistin concentrations in patients with restrictive and binge/purge form of anorexia nervosa and bulimia nervosa. J Clin Endocrinol Metab 90:1366–1370
Igaki N, Tanaka M, Goto T (2005) Markedly improved glycemic control and enhanced insulin sensitivity in a patient with type 2 diabetes complicated by a suprasellar tumor treated with pioglitazone and metformin. Intern Med 44(8):832–837
Iqbal N, Seshadri P, Stern L (2005) Serum resistin is not associated with obesity or insulin resistance in humans. Eur Rev Med Pharmacol Sci 9(3):161–165
Lammert A, Kiess W, Bottner A (2001) Soluble leptin receptor presents the main leptin binding activity in human blood. Biochem Biophys Res Commun 283:982–988
Lehrke M, Reilly MP, Millington SC (2004) An inflammatory cascade leading to hyperresistinemia in humans. PLoS Med 1:e45
Lustig RH (2006) Childhood obesity: behavioral aberration or biochemical drive? Reinterpreting the first law of thermodynamics. Nat Clin Pract Endocrinol Metab 2(8):447–458
Lustig RH, Hinds PS, Ringwald-Smith K (2003) Octreotide therapy of pediatric hypothalamic obesity: a double-blind, placebo-controlled trial. J Clin Endocrinol Metab 88(6):2586–2592
Lustig RH, Rose SR, Burghen GA (1999) Hypothalamic obesity caused by cranial insult in children: altered glucose and insulin dynamics and reversal by a somatostatin agonist. J Pediatr 135(2 Pt 1):162–168
McTernan PG, McTernan CL, Chetty R (2002) Increased resistin gene and protein expression in human abdominal adipose tissue. J Clin Endocrinol Metab 87:2407
Muse ED, Lam TK, Scherer PE, Rossetti L (2007) Hypothalamic resistin induces hepatic insulin resistance. J Clin Invest 117(6):1670–1678
Müller HL, Müller-Stöver S, Gebhardt U (2006) Secondary narcolepsy may be a causative factor of increased daytime sleepiness in obese childhood craniopharyngioma patients. J Pediatr Endocrinol Metab 19(Suppl 1):423–429
Pastucha D, Malincíková J, Hyjánek J (2007) Obesity and insulin resistance in childhood. Cent Eur J Public Health 15(3):103–105
Patel L, Cooper CD, Quinton ND, Butler GE, Gill MS, Jefferson IG, Kibirige MS, Price DA, Shalet SM, Wales JK, Ross RJ, Clayton PE, Northern Paediatric Endocrine Group, UK (2002) Serum leptin and leptin binding activity in children and adolescents with hypothalamic dysfunction. J Pediatr Endocrinol Metab 15(7):963–971
Proto C, Romualdi D, Cento RM (2007) Free and total leptin serum levels and soluble leptin receptors levels in two models of genetic obesity: the Prader Willi and the Down syndromes. Metabolism 56(8):1076–1080
Rangwala SM, Rich AS, Rhoades B (2004) Abnormal glucose homeostasis due to chronic hyperresistinemia. Diabetes 53(8):1937–1941
Reinehr T, Kratzsch J, Kiess W, Andler W (2005) Circulating soluble leptin receptor, leptin, and insulin resistance before and after weight loss in obese children. Int J Obes (Lond) 29(10):1230–1235
Rose SR, Schreiber RE, Kearney NS (2004) Hypothalamic dysfunction after chemotherapy. J Pediatr Endocrinol Metab 17(1):55–66
Roth C, Wilken B, Hanefeld F (1998) Hyperphagia in children with craniopharyngioma is associated with hyperleptinaemia and a failure in the downregulation of appetite. Eur J Endocrinol 138(1):89–91
Rutter MM, Rose SR (2007) Long-term endocrine sequelae of childhood cancer. Curr Opin Pediatr 19(4):480–487
Shaikh MG, Grundy R, Kirk J (2008) Hyperleptinaemia rather than fasting hyperinsulinaemia is associated with obesity following hypothalamic damage in children. Eur J Endocrinol, Sep 26 (in press)
Srinivasan S, Ogle GD, Garnett SP (2004) Features of the metabolic syndrome after childhood craniopharyngioma. J Clin Endocrinol Metab 89(1):81–86
Tiosano D, Eisentein I, Militianu D (2003) 11 beta-hydroxysteroid dehydrogenase activity in hypothalamic obesity. J Clin Endocrinol Metab 88(1):379–384
Zou CC, Liang L, Hong F (2007) Relationship between insulin resistance and serum levels of adiponectin and resistin with childhood obesity. Indian Pediatr 44(4):275–279
Acknowledgment
The authors would like to thank pediatric dietician Sabiha Keskin for caloric analyses of the children and SERONO Company who provided the commercial kits for serum leptin, soluble leptin receptor, and resistin.
Author information
Authors and Affiliations
Corresponding author
Additional information
This work has been presented in part in the free communication session of ESPE 2007 meeting (Helsinki-Finland, 2007).
Rights and permissions
About this article
Cite this article
Guran, T., Turan, S., Bereket, A. et al. The role of leptin, soluble leptin receptor, resistin, and insulin secretory dynamics in the pathogenesis of hypothalamic obesity in children. Eur J Pediatr 168, 1043–1048 (2009). https://doi.org/10.1007/s00431-008-0876-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00431-008-0876-x